Sanaria Inc.
Sanaria Inc.
Explore linked clinical trials.6 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Malaria CVD 36000; Gates INV090205 | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Not yet recruiting | Phase 1 | 2026-09-09 | NCT07558122 | |
| Challenge Trial of PfSPZ-LARC2 Vaccine in Burkina Faso | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Not yet recruiting | Phase 1 | 2026-07-31 | NCT07730177 | |
| PfSPZ-LARC2 Vaccine in Women of Child-bearing Potential (WOCBP) in Mali | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 2 | 2026-07-23 | NCT07675785 | |
| Safety, Tolerability and Efficacy of PfSPZ-LARC2 Vaccine Against CHMI in Malaria-Naïve Adults | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 1 | 2026-06-22 | NCT06862453 | |
| Field Trial of PfSPZ-LARC2 Vaccine in Burkinabe Adults | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 2 | 2026-06-01 | NCT07385287 | |
| Comparing Safety and Protective Efficacy of Vaccine Candidate PfSPZ-CVac and MVA ME-TRAP/ ChAd63 ME-TRAP in Adults | Infections, Mosquito-Borne Diseases, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Not yet recruiting | Phase 1 / Phase 2 | 2024-12-06 | NCT05441410 |